CEL-SCI News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.05.18	Mark Your Calendar For May 15, DXR Makes A Comeback, OBSV Abuzz, CVM On Watch (RTTNews)
11.04.18	SPPI Shines On NSCLC Data, TNDM Sales Up 42%, TORC Breathes Easy, VRAY Abuzz (RTTNews)
18.01.18	IIROC Trading Resumption - CVM (PR Newswire)
18.01.18	IIROC Trading Resumption - CVM (PR Newswire)
18.01.18	IIROC Trading Halt - CVM (PR Newswire)
18.01.18	IIROC Trading Halt - CVM (PR Newswire)
12.12.17	Earnings In Focus: Dec. 12 (ARWR, PAY) (RTTNews)
24.08.17	AZRX To Report Data In Sep., Long & Short Of PETS, IMUC Plunges, CLDX On Watch (RTTNews)
15.08.17	FDA Lifts Hold On CVM's Study, FATE On Track, REGN, OPHT, ZYNE All Flunk Trials (RTTNews)
13.06.17	XLRN's DART Misses Mark, RGLS Makes Cuts In Pipeline, FDA Snubs CHRS (RTTNews)
30.05.17	Lifshitz & Miller LLP Announces Investigation of Akari Therapeutics, Plc, Alexion Pharmaceuticals, Inc., Amgen Inc., Cel-Sci Corp., Dick's Sporting Goods, Inc., Eco Science Solutions, Inc. (PR Newswire)
06.04.17	Biotech Stocks on Investors' Radar -- Merrimack Pharma, Amicus Therapeutics, CEL-SCI, and Cempra (PR Newswire)
16.02.17	Research Reports Initiation on Biotech Stocks -- Heat Biologics, PDL BioPharma, Achaogen, and CEL-SCI (PR Newswire)
27.09.16	ARRY Hits COLUMBUS Goals, KITE Flies After-hrs, FDA Places Hold On CVM Trial (RTTNews)
27.09.16	CEL-SCI Says FDA Places Clinical Hold On Head And Neck Cancer Study (RTTNews)
02.07.15	GMED Expands Product Portfolio, CVM On Track, TCON To Get $3 Mln, REPH On Watch (RTTNews)
04.03.15	CPIX Returns To Black, ADMP Breathes Easy, TNXP For Long Haul, CERU Hits A High (RTTNews)
02.03.15	AMGN's Kyprolis Better Than Rival, KOOL Put On Notice, XON Inks Fruity Deal (RTTNews)
27.01.15	PFE Cuts Vaccine Price, CVM On Track, BABY Takes New Step, IPXL On A High (RTTNews)
21.10.14	CEL-SCI To Raise $1 Mln In Registered Direct Offering - Quick Facts (RTTNews)
03.10.14	CEL-SCI Issues Update On Phase III Immunotherapy Head And Neck Cancer Trial (RTTNews)
04.09.14	Sweet News For ABT, Adherex To Change Name, FLXN's Work In Progress, INFI Rises (RTTNews)
03.09.14	CEL-SCI Enrolls 20 Patients In Aug. In Multikine Phase III Study - Quick Facts (RTTNews)
19.08.14	CEL-SCI Extends Its Phase III Head And Neck Cancer Trial To Canada (RTTNews)
17.07.14	CEL-SCI Expands Late-stage Head And Neck Cancer Trial Into Sri Lanka (RTTNews)
08.07.14	CEL-SCI Gets Clearance To Expand Phase III Head & Neck Cancer Trial Into Austria (RTTNews)
01.07.14	CEL-SCI : Patient Enrollment In Late-stage Head And Neck Cancer Trial Rises (RTTNews)
14.04.14	CEL-SCI Prices $10 Mln Offering Of Common Stock, Warrants (RTTNews)
23.01.14	CEL-SCI Says Serbia Approves Enrollment Of Subjects In Multikine Phase III Trial (RTTNews)
26.12.13	CEL-SCI Closes Underwritten Public Offering - Quick Facts (RTTNews)
05.12.13	CEL-SCI To Commence Phase III Trial Of Multikine In Bosnia And Herzegovina (RTTNews)
07.10.13	CEL-SCI Announces Proposed Public Offering Of Common Stock, Warrants (RTTNews)
07.10.13	ATOS Crushed, CVM Gets Grace Period, DSCO Soars, MNOV On The Watch (RTTNews)
12.11.09	Is Amendment of Previously Filed Paperwork a Sign That CEL-SCI is Expecting Something Big? (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Geberit	510.00	3.09 %	K V
UBS Group	29.96	1.97 %	K V
Zurich Insur Gr	537.60	1.55 %	K V
Logitech Intl	80.34	1.47 %	K V
Swiss Life Hldg	717.00	1.36 %	K V
Kuehne+Nagel Int	200.90	0.45 %	K V
Swisscom	509.00	0.30 %	K V
Alcon	75.84	0.18 %	K V
Nestle	73.66	-0.67 %	K V
CieFinRichemont	139.05	-0.82 %	K V

Nachrichten zu CEL-SCI Corp.

Aktien Top/Flop

Meistgelesene Nachrichten